Clinical Trial

Preoperative Sleep Quality and Postoperative Outcomes in Breast Surgery

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated April 30, 2026 (before its estimated July 1, 2026 completion). Its status may not reflect the trial's current state.
Summary
Sleep quality is a key physiological factor influencing immune function, inflammatory response, and pain perception. This prospective observational study aims to evaluate whether preoperative sleep quality predicts postoperative inflammation, pain severity, and analgesic consumption in patients undergoing elective breast cancer surgery. Preoperative sleep quality will be assessed using the Pittsburgh Sleep Quality Index (PSQI). Systemic inflammatory response will be evaluated using the Systemic Immune-Inflammation Index (SII), calculated from routine hematological parameters. Postoperative pain will be assessed using the Visual Analog Scale (VAS), and analgesic consumption will be recorded within the first 24 hours. The study aims to determine whether poor sleep quality is associated with increased inflammatory response, higher pain scores, and greater analgesic requirement.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2026-04-17; most recent amendment 2026-04-26.
Trial Details
NCT Number NCT07547774
Lead Sponsor Dr Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital
Conditions Breast Cancer, Postoperative Pain, Inflammation
Enrollment 150 participants
Start Date 2026-04-01
Primary Completion 2026-07-01 (estimated)
Study Completion 2026-07-15 (estimated)
Updated on ClinicalTrials.gov 2026-04-30